<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Proc. Nadl. Acad. Sci. USA <br /> Vol. 82, pp. 4189-4192, June 1985 <br /> Genetics <br />  <br />  <br />  <br /> Bacillus subtilis factor CF29 product sporulation-essential gene spoIIG <br />      (bacterial sporulation/monoclonal antibody) <br /> JANINE E. TREMPY*, CELINE BONAMYt, JEKISIEL SZULMAJSTERt, WILLIAM G. HALDENWANG* <br /> *Department Microbiology, University Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78284; tLaboratoire d&apos;Enzymologie <br /> du Centre National la Recherche Scientifique, 91190 Gif-Sur-Yvette, France <br /> Communicated Jesse C. Rabinowitz, February 22, 1985 <br />  <br /> ABSTRACT           Evidence presented sporulation-                       early stage development lie map position 130 <br /> essential locus spolIG codes 29 structurally                          B. subtilis chromosome (10, 11). sporulation-es- <br /> related protein, P31. demonstrates specific                   sential gene recently cloned sequenced (12). <br /> Bacilus subtilis RNA polymerase binding protein provides                           likely product spolIG, inferred DNA sequence <br /> critical function endospore formation. spoIIG-specific RNA                        data, Mr 27,500 protein carries regions homology present B. subtilis cultures synthesizing p3&apos;                     major E. coli ar factor encoded rpoD (12). Based 29 absent  monoclonal antibody                      size, time expression, homology rpoD, spoIIG <br /> specific antigenic determinant P31/cr29 detected                           suggested structural gene or29 (12). <br /> crossreacting proteins (P25/P21) P3&apos; cy29 Spo- B.                      analyzed possible relationship subtilis strain mutation spolIG locus (spoIIG41).                      spoIIG o.29 monoclonal antibody (8) specific appearance P25 P21 occurs mutant time                        antigenic site exclusively present P3&apos; ,29. P31 Ca29 normally appear suggests                            experiments indicate sporulation-essential locus homologous proteins. Transformation spoIlG41                         spoIIG structural gene P31 o,29.  strain plasmid DNA carrying structural gene                             proteins play critical role endospore <br /> spolIG complements Spo- phenotype results                             formation. <br /> synthesis P31, 29 p25, P21 appropriate times sporulation. Escherichia coli, cloned spolIG                                        MATERIALS METHODS <br /> sequence encoded protein reacted anti-P31/Oa&apos;29 <br /> monoclonal antibody electrophoretic mobility                            Bacterial Strains. B. subtilis strains BS50 (spoIIG41) authentic P31.                                                                       BS119 (spoIIG55) obtained M. Young; SMY                                                                                      R. Losick; NG 17.15, P9, 26U spore-forming bacterium Bacillus subtilis synthesizes                         Bacillus Stock Center (Ohio State University). E. coli strain forms DNA-dependent RNA polymerase,                              C600 obtained B. Eisenstein. relevant pheno- distinguished promoter specificity determinant (o,                        types strains indicated figure legends. <br /> factor) carries common core enzyme (1-5).                                RNA Analysis. B. subtilis cells grown Sterlini  factors, cr29, protein (Mr, 29,000)                       Mandelstam resuspension medium (13). RNA vegeta- <br /> detected endospore formation                           tive sporulating [2 hr (T2) 4 hr (T4) sporulation] <br /> predicted important element spore gene regulation                        cells prepared described Gilman Chamberlin <br /> (3, 6, 7). Recently, protein (P31; Mr, 31,000), structurally                       (4) disruption cells passage Eaton <br /> related v.29, identified extracts sporulating B.                        pressure cell (5000 psi; 1 psi = 6.895 x 103 Pa). RNA subtilis (8). p31 reacts monoclonal antibody                          spotted nitrocellulose probed spoIIG-specific <br /> specific antigenic site or29. addition, p31 o,29                    DNA [1.1-kilobase-pair Pst fragment (12)] labeled <span id='am-1' about='obo:IMR_0001700' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-2' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:id" content="IMR:0001700" datatype="xsd:string"></span><span id='am-4' property="rdfs:label" content="peptide" datatype="xsd:string"></span><span id='am-5' property="obo:IAO_0000115" content="The polypeptide that is not a gene product." datatype="xsd:string"></span>peptide</span> profiles digested                             nick-translation reaction DNA polymerase  <br /> Staphylococcus aureus V8 chymotrypsin A4 protease (ref.                              Analysis Cell Extracts Monoclonal Antibody. 9; unpublished results). sporulation, synthesis p31                        isolation production monoclonal antibody, precedes 29 occurs Bacillus species B.                      methods cell extract preparation analysis, subtilis Spo- mutants capable                                described (8). <br /> synthesizing or29-like protein (8). p31, like ao29, capable associating core RNA polymerase. RNA polymerase                                                           RESULTS carries P3&apos; (E-p31) elution pattern DNA-cel- <br /> lulose identical RNA polymerase carrying ar29                             p31 or29 appear B. subtilis early stage (E-a29) (9). P31 29 differ biochemically P3&apos; binds                     sporulation absent vegetatively growing cells (8). <br /> relatively poorly RNA polymerase resulting E-P31                           spoIIG codes p31 29, RNA homologous detectable activity cloned B. subtilis DNAs (9).                       spoIIG DNA present sporulating cells. <br /> properties p31 o29 indicate likely                    RNA extracted vegetatively growing sporulat- <br /> products structural gene, p31 potentially                        ing cells (T2 T4), spotted nitrocellulose paper, inactive precursor cr29.                                                          hybridized 32P-labeled spoIIG DNA. Fig. 1 shows    genetic locus spoIIG defined number                                spoIIG sequence absent RNA obtained independently isolated mutations block spore formation                          vegetatively growing cells (lane 1), present 2 hr <br />                                                                                      sporulation (lane 2). number B. subtilis Spo- <br />  publication costs article defrayed page charge          mutants, blocked morphological stage develop- <br />  payment. article marked &quot;advertisement&quot;               ment (stage II), vary ability synthesize p31 a29 <br />  accordance 18 U.S.C. &#194;&#167;1734 solely indicate fact.                    (8). mutants probed spoIIG-specific <br />                                                                               4189 <br />  4190      Genetics:   Trempy et al.                                                       Proc. Natl. Acad. Sci. USA 82 (1985) <br />                                                                                                    _      3     4      -5     6 <br />  <br />                                         ANOL.    ANIL. <br />                                         JIM&quot;..   0 <br />                                    rl   w <br />  <br />  <br />                                                                                                                                              p.,  <br />                                                                                                                                                   2( <br />                                                                                                                                              (T <br />                                                                              p1i <br />                                                          -_-- 4              p&apos;-   _I<span id='am-6' about='obo:IMR_0200083' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-7' property="oboInOwl:id" content="IMR:0200083" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasExactSynonym" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:hasDbXref" content="KEGG:C00020" datatype="xsd:string"></span><span id='am-10' property="rdfs:label" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-11' property="rdfs:label" content="AMP" datatype="xsd:string"></span><span id='am-12' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>amp</span>; <br />  <br />  <br />  <br />  <br />                                                          -*o    6 <br />  <br />                                                          -46-   11 <br />  <br />                                                                               FIG. 2. Immunological analysis o 29/P3&apos; spoIIG mutants. <br />                                                                            Crude protein extracts prepared described (8) B. <br />                                                                            subtilis cells harvested 2 hr (T2) 3.5 hr (T3.5)                                                                            onset sporulation DS medium (15). Portions (100 /Ag)                                                    p:           t3 <br />                                                                            fractionated electrophoresis 12% NaDodSO4/polyacrylamide <br />                                                           .- <br />                                                                            gels, transferred electrophoretically nitrocellulose, probed <br />                                                                            monoclonal antibody (8). Bound antibody visualized                                                            -    10         horseradish peroxidase-conjugated goat IgG mouse Ig <br />                                                                            (HyClone). Lanes: 1 2, BS119 (spoIIG55) T2 T3.5, respec- <br />                                                                            tively; 3 4, BS50 (spoIIG41) T2 T3.5, respectively; 5 6, <br />                                                          ~-     11         SMY (Spo+) T2 T3.5, respectively. <br />  <br />                                                                            strain (Fig. 3A) spoIIG41 mutant (Fig. 3B).                                                                            expected homologous proteins, pattern synthesis                                                                            proteins capable reacting monoclonal antibody <br />   FIG. 1. Dot blot analysis B. subtilis RNA spolIG            se- <br />                                                                            appears similar Spo+ mutant strains, quences. Increasing amounts RNA (1.25, 2.5, 5, 10, 20, 40 ,Lg <br />                                                                            synthesis p31 p25 preceding appearance .29 spot) vegetative cells cells harvested 2 hr (T2)     p21. <br /> 4 hr (T4) sporulation spotted nitrocellulose paper         spoIIG cloned DNA isolated sequence hybridized 6.7 x 106 cpm 32P-labeled spofIG DNA. Lanes:            corrected Spo- phenotype spoIIG mutations <br /> 1-3, B. subtilis 168M (Spo+) (vegetative, T2, T4); 4-6, B. subtilis NG     (spoIIG41 spoIIGSS) vivo (12). pGSIIG11 B. <br /> 17.15 (spoIIE64-oI29 absent, P31 present) (vegetative, T2, T4); 7-9, B.    subtilislE. coli shuttle plasmid carries entire spolIG <br /> subtilis P9 (spoIIC298-o29 p31 present) (vegetative, T2, T4);          structural gene sequence, plus 100 200 base pairs B. <br /> 10-12, B. subtilis 26u (spoIIA26-o 29 p31 absent) (vegetative, T2,     subtilis DNA flank end gene, cloned <br /> T4).                                                                       1.1-kilobase-pair DNA fragment (12). pGSIIG11                                                                            introduced spoIIG41 strain, transformants syn- <br /> RNA, spoIIG RNA present end                   thesize p25 p21 proteins mobility <br /> exponential growth mutant strain synthesizes p31             authentic p31 29 (Fig. 4, lanes 1 2).  Co29 (spoIIC; lanes 7-9) p31 (spoIIE; lanes 4-6),          plasmid DNA sequence did affect synthesis strain fails synthesize proteins              defective P31/cr29 proteins instead supplemented (spoIIA; lanes 10-12). spoIIG RNA present cells                 synthesis normal sized p31 cr29. simplest synthesizing P31/cr29 absent cells            explanation results, given physical similarities <br />    prepared crude protein extracts B.                     p31 a29, spoIIG defines structural <br /> subtilis strains carry mutant alleles spoIIG (spoIIG41             gene p31 o.29 gene defective spoIIG55) analyzed size-fractionation                   spoIIG41 mutant. Possibly, spoIIG41 carries nonsense <br /> NaDodSO4/polyacrylamide gels followed transfer ni-                   mutation leading synthesis truncated p31  e., P25) <br /> trocellulose paper probing anti-o-29/P31 mono-                 cr29  e., p21). <br /> clonal antibody. antibody readily detects p31 29                able verify directly structural gene extracts sporulating B. subtilis (Fig. 2, lanes 5 6).               P31 carried pGSIIG11 introducing plasmid E. spolIG mutants synthesized detectable                       coli screening extracts plasmid-containing strains amounts p31 v.29 (lanes 1-4),                   anti-P31/cr29 antibody. E. coli carried plasmid syn- <br /> (spoIIG41) produced proteins [Mr, 25,000 (p25); Mr,                    thesized protein reacted antibody 21,000 (p21)] reacted o29/P31-specific antibody              electrophoretic properties authentic P31 (Fig. 4, lane 4). <br /> (lanes 3 4). presence mutant aberrantly                 spoIIG sequence carried pGSIIG11 cloned sized proteins react o-29/P31-specific antibody absence p31 o.29 suggest spoIIG defect             8-lactamase gene plasmid vector (12). Expression directly affect synthesis p31 cr29.                  p3&apos; protein E. coli transcription <br />    previously determined p31 r29 appear                 initiating 3-lactamase promoter. transcriptional precise time endospore formation (8). proteins              fusion ,-lactamase spoIIG account spoIIG41 strain recognized P31/29                      observation spoIIG-specific RNA present antibody similarly regulated, argue                vegetative B. subtilis cells carry pGSIIG11 (unpub-  fact, counterparts p31 o.29 mutant.            lished data). pGSIIG11 leads synthesis Fig. 3 shows analysis temporal appearance                 p31 29 spoIIG41 strain, unable proteins react anti-o-29 antibody Spo+ B. subtilis          detect u29 pGSIIG11-containing E. coli strain. Presum- <br />                   Genetics:     Trempy et                                                    Proc. Natl. Acad. Sci. USA 82 (1985)            4191 <br />  <br />                                T1            T3                           endospore formation B. subtilis (16). data presented                                                                               paper support suggestion. report                                                                                 RNA polymerase binding proteins P3&apos; -29                                                                                 products sporulation essential locus (spoIIG). <br />                                                                                     development heat-resistant endospores B. subtilis <br />                                                                   pTl           occurs -8 hr onset differentiation. Spo- mutants <br />                                                                                 blocked stage II development (e.g., spolIG) char- <br />                                                                                 acterized ability divide forespore mother <br />                                                                                 cell compartments unable develop                                                                                 point (17). asymmetric cell division normally ac- <br />                                                                                 complished second hour development (T2) (18). T2 <br />                                                                                 time o29 abundant sporulating <br />                                                                                 cells (8).  defect sporulation does prevent <br />                                                                                 cells reaching stage II arrests development                                                                                 stage expected phenotype associated                                                                                 loss o.29 function  e., interruption sporulation T2). <br />                                                                                      Previous biochemical evidence supported present <br />                                                                                 study indicates P3&apos; v.29 products                        B                                                        structural gene (8, 9). apparent structural gene                                                                                 proteins cloned sequenced,                                                                                 survey primary structure spolIG product                                                                                 characteristics bear speculation c 29 <br />                                                                                 derived P31. obvious modification                                                                                 yield cr29 proteolysis ends                                                                                 P3&apos; molecule. &quot;truncated&quot; proteins                                                             -+- Pr-             spoIIG41 mutant (p25 p2l) counterparts P3&apos;                                                                                   29 result proteolytic degradation mutant <br />                                                                                 protein, argued amino-terminal <br />                                                             _--    P21           portion molecule critical region processing. <br />                                                                                  Limited digestion P31 S. aureus V8 protease results <br />                                                                                  generation protein carries P311/o29 <br />                                                                                  common epitope electrophoretic mobility similar <br />   FIG. 3. Time               course   p31/cI29 accumulation. Crude protein    29 (ref. 9; unpublished results). protein extracts (100 jig) SMY (Spo&apos;)   BS50 (spoIIG4l) (B),                   slowly digested overlapping peptides, harvested hourly intervals sporulation DS medium (15),              represent partial digestion products identifiable size-fractionated NaDodSO4/PAGE (15% acrylamide),                        anti-P31/af29 monoclonal antibody. peptides <br /> transferred nitrocellulose, probed anti 29 antibody             appear identical digestion products obtained described Fig. 1.  end exponential growth; T1, 1 hr           similar reaction authentic a29 (8, 9). late                                                                           digestion products P3&apos; cr29 appear  <br />                                                                                  distinguishable, assume Mr <br /> ably, E. coli lacks necessary factor synthesize a29                   29,000 initial digestion product p31 protein process             P31.                                              similar authentic a2. <br />                                                                                      S. aureus V8 protease specifically cleaves peptide bonds <br />                                       DISCUSSION                                 carboxyl-terminal site aspartic acid                                                                                  <span id='am-20' about='obo:IMR_0100119' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001695 obo:IMR_0000001 obo:IMR_0100116'><span id='am-21' property="oboInOwl:hasAlternativeId" content="IMR:0200156" datatype="xsd:string"></span><span id='am-22' property="oboInOwl:hasExactSynonym" content="L-Glutamic acid" datatype="xsd:string"></span><span id='am-23' property="rdfs:label" content="L-Glutamic acid" datatype="xsd:string"></span><span id='am-24' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-25' property="oboInOwl:hasDbXref" content="KEGG:C00025" datatype="xsd:string"></span><span id='am-26' property="oboInOwl:hasExactSynonym" content="L-Glutamate" datatype="xsd:string"></span><span id='am-27' property="rdfs:label" content="L-Glutamate" datatype="xsd:string"></span><span id='am-28' property="rdfs:label" content="glutamic acid" datatype="xsd:string"></span><span id='am-29' property="oboInOwl:hasExactSynonym" content="L-Glutaminic acid" datatype="xsd:string"></span><span id='am-30' property="oboInOwl:id" content="IMR:0100119" datatype="xsd:string"></span><span id='am-31' property="rdfs:label" content="L-Glutaminic acid" datatype="xsd:string"></span>glutamic acid</span> (19). predicted <span id='am-13' about='obo:IMR_0001695' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-14' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-15' property="rdfs:label" content="amino acid" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:id" content="IMR:0001695" datatype="xsd:string"></span><span id='am-17' property="oboInOwl:hasDbXref" content="CHEBI:33709" datatype="xsd:string"></span><span id='am-18' property="obo:IAO_0000115" content="Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins." datatype="xsd:string"></span><span id='am-19' property="oboInOwl:hasDbXref" content="MeSH:D000596" datatype="xsd:string"></span>amino acid</span> sequence suggested RNA polymerase modification                        spoIIG gene product (12) examined, S. aureus protease critical mechanism(s) activating genes                      cleavage site 24 amino acids amino- <br />                                                                                  terminal end molecule (Fig. 5). Cleavage site <br />                                   1       2        3    4         &gt;              remove fragment Mr -3500 parent <br />                                                                                  protein. assume fragment accounts                                                                                   estimated Mr 2000 difference p31 or29                                                                                   Mr 4000 difference p25 P2l calcu- <br />                                                                                   lated based gel migration properties. specula- <br />                     P31- <br />                                                                                   tions correct, formation active cr factor, a29,                                                                                   p31 involve removal equivalent                        (F9                                                        24-amino acid fragment. <br />                                                                                       Does hypothetically processed amino-terminal se- <br />                                                                                   quence spoIlIG (p31) resemble processed <br />                                                                                   proteins? certain similarity pro- <br />                    P21                                                            karyotic signal sequences involved transport <br />                                                                                   membranes. known signal sequences,                                                                                   positively charged amino-terminal sequence (amino acids <br />                                                                                   1-5), region relatively rich hydrophobic amino acids <br />                                                                                   (amino acids 6-21), amino acid small R group <br />       FIG. 4.      Complementation p31/cr pGSlIG11. Crude pro-            (serine) near proposed cleavage site (20). similarity <br /> tein extracts        prepared analyzed described Fig. 1.           intriguing given report 61  e., r&apos;2) compart- <br /> Lanes        1      2, BS50/pGSIIG11 DS medium (15) T2 T3.5,           mentalized fores ores (14). sequence plays respectively; lane 3, SMY (Spo&apos;) T2 DS medium; lane 4, E. coli                 role targeting v9 developing forespore. Alterna- <br /> strain C600/pGS1IG11 mid-logarithmic phase LB medium; lane 5,                  tively, resemblance region P31, suggested E. coli strain C600 mid-logarithmic phase LB medium (15).                      lost processing, prokaryotic signal sequences  4192     Genetics: Trempy          et   al.                                                                       Proc. Natl. Acad. Sci. USA 82 (1985) <br />                                1         2         3        4        5         6         7         8         9         10      11    12 <br />                           fMet          Lys    Lys      Leu      Lys           Leu Arg             Leu Thr                Leu Trp <br />  <br />  <br />                           13        14        15       16       17       18        19        20        21        22     23      24 <br />                                                                                                                                      +    25 <br />                          Tyr        Lys       Leu      Leu      Met      Lys       Leu       <span id='am-32' about='obo:IMR_0100118' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001695 obo:IMR_0000001 obo:IMR_0100116'><span id='am-33' property="oboInOwl:id" content="IMR:0100118" datatype="xsd:string"></span><span id='am-34' property="rdfs:label" content="Glycine" datatype="xsd:string"></span><span id='am-35' property="oboInOwl:hasExactSynonym" content="Aminoacetic acid" datatype="xsd:string"></span><span id='am-36' property="oboInOwl:hasExactSynonym" content="Gly" datatype="xsd:string"></span><span id='am-37' property="oboInOwl:hasDbXref" content="KEGG:C00037" datatype="xsd:string"></span><span id='am-38' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-39' property="rdfs:label" content="glycine" datatype="xsd:string"></span><span id='am-40' property="oboInOwl:hasExactSynonym" content="Glycine" datatype="xsd:string"></span><span id='am-41' property="rdfs:label" content="Aminoacetic acid" datatype="xsd:string"></span><span id='am-42' property="rdfs:label" content="Gly" datatype="xsd:string"></span><span id='am-43' property="oboInOwl:hasAlternativeId" content="IMR:0200057" datatype="xsd:string"></span>Gly</span>       Leu       Lys    Ser    Asp        Glu <br />   FIG. 5. Amino acid sequence amino-terminal portion spolIG protein. amino-terminal sequence spolIG protein predicted Stragier et al. (12) illustrated, arrow indicating predicted S. aureus protease site mimics p3&apos; 0 29 conversion. <br />  <br /> reflect structural feature proteins proteolytically                             6. Linn, T., Greenleaf,  L. &amp; Losick, R. (1975) J. Biol. Chem. <br /> processed indicate particular protein                                   250, 9256-9261. <br /> transported.                                                                                  7. Fukuda, R. &amp; Doi, R. (1977) J. Bacteriol. 129, 422-432. <br />    Unraveling relationship P31 o.29 likely                              8. Trempy, J. E., Morrison-Plummer, J. &amp; Haldenwang, W. G. <br /> reveal mechanisms ofgene control uniquely suited                                     (1985) J. Bacteriol. 161, 340-346. <br />                                                                                               9. Trempy, J. E.,  <br /> </body></html>